These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 32970275)

  • 21. [TAFRO syndrome and monoclonal gammapathy: Uncommon association!].
    Naifar M; Messedi M; Elleuch A; Snoussi M; Gouiaa N; Turki M; Lahiani A; Boudawara T; Bahloul Z; Ayedi F
    Curr Res Transl Med; 2016; 64(1):43-7. PubMed ID: 27140598
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatic Campylobacter jejuni infection in patients with Castleman-Kojima disease (idiopathic multicentric Castleman disease with thrombocytopenia, anasarca, fever, reticulin fibrosis, and organomegaly (TAFRO) syndrome).
    Kageyama C; Igawa T; Gion Y; Iwaki N; Tabata T; Tanaka T; Kondo E; Sakai H; Tsuneyama K; Nomoto K; Noguchi H; Yoshino T; Yokota K; Sato Y
    Pathol Int; 2019 Oct; 69(10):572-579. PubMed ID: 31631463
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the clinical characteristics of TAFRO syndrome and idiopathic multicentric Castleman disease in general internal medicine: a 6-year retrospective study.
    Nishimura Y; Hanayama Y; Fujii N; Kondo E; Otsuka F
    Intern Med J; 2020 Feb; 50(2):184-191. PubMed ID: 31211492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A pediatric case of tocilizumab-resistant TAFRO syndrome treated successfully with rituximab.
    Minamikawa S; Matsumura O; Sato S; Nakagishi Y; Tanaka R
    Pediatr Blood Cancer; 2020 Dec; 67(12):e28489. PubMed ID: 32568456
    [No Abstract]   [Full Text] [Related]  

  • 25. Stepwise Treatment for TAFRO Syndrome.
    Ide M; Yokoyama T; Ishikawa M; Kojima K
    J Med Cases; 2023 Nov; 14(11):369-377. PubMed ID: 38029058
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A case of TAFRO syndrome, a variant of multicentric Castleman's disease, successfully treated with corticosteroid and cyclosporine A.
    Takasawa N; Sekiguchi Y; Takahashi T; Muryoi A; Satoh J; Sasaki T
    Mod Rheumatol; 2019 Jan; 29(1):198-202. PubMed ID: 27413814
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patient's age and D-dimer levels predict the prognosis in patients with TAFRO syndrome.
    Kawabata H; Fujimoto S; Sakai T; Yanagisawa H; Kitawaki T; Nara K; Hagihara M; Yamamoto H; Tanimizu M; Kato C; Origuchi T; Sunami K; Sunami Y; Masunari T; Nakamura N; Kobayashi M; Yamagami K; Miura K; Takai K; Aoki S; Tsukamoto N; Masaki Y
    Int J Hematol; 2021 Aug; 114(2):179-188. PubMed ID: 33929719
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute Kidney Injury Caused by TAFRO Syndrome in a Chinese Patient: Efficacy of Long-Term Corticosteroids Combined with Bortezomib and Cyclophosphamide.
    Xia P; Zhang L; Zou M; Zhang T; Li R; Shi X; Wang J; Qin Y; Li X; Li J; Chen L
    Kidney Blood Press Res; 2020; 45(4):623-630. PubMed ID: 32492687
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is TAFRO syndrome a subtype of idiopathic multicentric Castleman disease?
    Fujimoto S; Sakai T; Kawabata H; Kurose N; Yamada S; Takai K; Aoki S; Kuroda J; Ide M; Setoguchi K; Tsukamoto N; Iwao-Kawanami H; Kawanami T; Mizuta S; Fukushima T; Masaki Y
    Am J Hematol; 2019 Sep; 94(9):975-983. PubMed ID: 31222819
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TAFRO syndrome is associated with anti-SSA/Ro60 antibodies, in contrast to idiopathic castleman disease.
    Shirakashi M; Nishida Y; Nakashima R; Fujimoto M; Hiwa R; Tsuji H; Kitagori K; Akizuki S; Morinobu A; Yoshifuji H
    Sci Rep; 2024 Feb; 14(1):2889. PubMed ID: 38311632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Successful treatment of a patient with multicentric Castleman's disease who presented with thrombocytopenia, ascites, renal failure and myelofibrosis using tocilizumab, an anti-interleukin-6 receptor antibody.
    Kawabata H; Kotani S; Matsumura Y; Kondo T; Katsurada T; Haga H; Kadowaki N; Takaori-Kondo A
    Intern Med; 2013; 52(13):1503-7. PubMed ID: 23812199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A life-threatening case of TAFRO syndrome with dramatic response to tocilizumab, rituximab, and pulse steroids: The first case report in Latin America.
    José FF; Kerbauy LN; Perini GF; Blumenschein DI; Pasqualin DDC; Malheiros DMAC; Campos Neto GC; de Souza Santos FP; Piovesan R; Hamerschlak N
    Medicine (Baltimore); 2017 Mar; 96(13):e6271. PubMed ID: 28353560
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathological findings of progressive renal involvement in a patient with TAFRO syndrome.
    Saito H; Tanaka K; Fujiwara M; Iwasaki T; Numata T; Oda A; Kanno M; Tanaka M; Eiro M; Satoh M; Kazama JJ
    CEN Case Rep; 2019 Nov; 8(4):239-245. PubMed ID: 31077056
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dysmorphic megakaryocytes in TAFRO syndrome: A case series from a single institute.
    Maida S; Nakagawa H; Ureshino H; Kajihara K; Yamazaki S; Ichinohe T
    Blood Cells Mol Dis; 2024 Sep; 108():102870. PubMed ID: 38901333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TAFRO Syndrome with Disseminated Intravascular Coagulation Successfully Treated with Tocilizumab and Recombinant Thrombomodulin.
    Takayama Y; Kubota T; Ogino Y; Ohnishi H; Togitani K; Yokoyama A
    Intern Med; 2018 May; 57(9):1291-1296. PubMed ID: 29279488
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Computed tomography findings of early-stage TAFRO syndrome and associated adrenal abnormalities.
    Kurokawa R; Gonoi W; Yokota H; Isshiki S; Ohira K; Mizuno H; Kiguchi T; Inui S; Kurokawa M; Kato S; Matsuki M; Takeda T; Yokoyama K; Ota Y; Nakai Y; Maeda E; Mori H; Abe O
    Eur Radiol; 2020 Oct; 30(10):5588-5598. PubMed ID: 32440781
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment consistent with idiopathic multicentric Castleman disease guidelines is associated with improved outcomes.
    Pierson SK; Lim MS; Srkalovic G; Brandstadter JD; Sarmiento Bustamante M; Shyamsundar S; Mango N; Lavery C; Austin B; Alapat D; Lechowicz MJ; Bagg A; Li H; Casper C; van Rhee F; Fajgenbaum DC
    Blood Adv; 2023 Nov; 7(21):6652-6664. PubMed ID: 37656441
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment-resistant idiopathic multicentric Castleman disease with thrombocytopenia, anasarca, fever, reticulin fibrosis, renal dysfunction, and organomegaly managed with Janus kinase inhibitors: A case report.
    Kakutani T; Nunokawa T; Chinen N; Tamai Y
    Medicine (Baltimore); 2022 Dec; 101(48):e32200. PubMed ID: 36482523
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complete Resolution of a Case of TAFRO Syndrome Accompanied by Mediastinal Panniculitis, Adrenal Lesion, and Liver Damage with Hyperbilirubinemia.
    Ono S; Yoshimoto K; Nishimura N; Yoneima R; Kawashima H; Kobayashi T; Tai Y; Miyamoto M; Tsushima E; Yada N; Nishio K
    Intern Med; 2021 Apr; 60(8):1303-1309. PubMed ID: 33191324
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A severe case of thrombocytopenia, anasarca, fever, renal insufficiency or reticulin fibrosis, and organomegaly syndrome with myocardial and skeletal muscle calcification despite hypocalcemia: a case report.
    Minomo S; Fujiwara Y; Sakashita S; Takamura A; Nagata K
    J Med Case Rep; 2021 Jan; 15(1):3. PubMed ID: 33402219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.